Transglutaminase-mediated conjugation
US11920136B2 · kind B2 · utility
1Cited by
46References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2021 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Oct 10, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides for antibody-oligonucleotide conjugates, methods of preparation thereof, and methods of use thereof. Also provided are related compounds, compositions and kits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.